Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
07 May 2024
General Assembly, General meetings

Rapport des commissaires aux comptes sur les états financiers consolidés 2023 en normes IFRS Open in new window

07 May 2024
General Assembly, General meetings

Rapport des commissaires aux comptes sur les états financiers annuels 2023 en normes françaises Open in new window

07 May 2024
General Assembly, General meetings

Avis préalable à l’Assemblée Générale 2024 Open in new window

07 May 2024
General Assembly, General meetings

AGM 2024 – Board nominees Open in new window

07 May 2024
General Assembly, General meetings

Shares and voting rights statement – 2024 General Meeting Open in new window

07 May 2024
General Assembly, General meetings

Formulaire de vote par correspondance – AGM 2024 Open in new window

07 May 2024
General Assembly, General meetings

Gensight Brochure de convocation AG 2024 Open in new window

07 May 2024
Regulated information

Securities Note Open in new window

07 May 2024
Financial statements and reports, Regulated information

AMENDMENT TO THE 2023 UNIVERSAL REGISTRATION DOCUMENT Open in new window

17 April 2024
Financial statements and reports

2023 Universal Registration Document Open in new window

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 23
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page